Glial cells in amyotrophic lateral sclerosis
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
For more than twenty years glial cells have been implicated in the pathogenetic cascades for genetic and sporadic forms of ALS. The biological role of glia, including the principal CNS glia, astroglia and oligodendroglia, as well as the myeloid derived microglia, has uniformly led to converging data sets that implicate these diverse cells in the degeneration of neurons in ALS. Originating as studies in postmortem human brain implicating astroglia, the research progressed to strongly implicate microglia and contributors to CNS injury in all forms of ALS. Most recently and unexpectedly, oligodendroglia have also been shown in animal model systems and human brain to play an early role in the dysfunction and death of ALS neurons. These studies have identified a number of diverse cellular cascades that could be, or have already been, the target of therapeutic interventions. Understanding the temporal and regional role of these cells and the magnitude of their contribution will be important for future interventions. Employing markers of these cell types may also allow for future important patient subgrouping and pharmacodynamic drug development tools.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 1×
“Moreover, pathology associated with a very rare genetic form of ALS, TDP-43, is thought to be involved in disease pathogenesis in the majority of ALS patients (Neumann et al., 2006).”
BackgroundDanbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Pellerin, L., & Magistretti, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10625 · Cited by 2,927 · cited 1×
“Under conditions of increased neuronal activity and metabolic substrate demand, astrocytes increase their glycolytical activity, converting glucose to lactate (Pellerin and Magistretti, 1994).”
BackgroundOligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664 · cited 9×
“…through which metabolic substrates like lactate and ketone bodies together with hydrogen ions are being exported and subsequently provided to neurons, especially at regions of close neuronal contact like at the paranodal region as well as at the Schmidt-Lanterman incisures (Lee et al., 2012).”
BackgroundInfluentialSelf-citationOnset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523 · cited 1×
“Both glucose and lactate are hypothesized to be distributed by astrocytes and gapjunction connected oligodendrocytes throughout the parenchyma and used as an energy substrate by neurons (Funfschilling et al., 2012; Lee et al., 2012).”
Backgroundβ-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518 · cited 1×
“Enhancement of GLT-1 levels by transgenic overexpression (Guo et al., 2003) or by treatment of mSOD1 mice with ceftriaxone increases mSOD1 mice life span (Rothstein et al., 2005).”
BackgroundSelf-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341 · cited 5×
“…by proliferation of resident astroglia, but rather by activation of pre-existing resident astrocytes and a change in their expression of proteins (e.g. increased GFAP, decreased GLT1) and altered morphology of their fine processes (Bruijn et al., 1997; Gowing et al., 2008; Lepore et al., 2008a).”
BackgroundInfluentialSelf-citationAstrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140 · cited 3×
“Similar to microglia, deletion of mSOD1 G37R from astrocytes delayed disease progression and extended survival (Yamanaka et al., 2008a).”
BackgroundResultDisruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036 · cited 2×
“In addition, mice lacking the expression of specific oligodendrocyte markers like PLP and CNPase develop axonal degeneration independent of widespread demyelination, again suggesting that oligodendrocytes (and Schwann Cells in the periphery), independent of their function as generating the myelin sheath, are instrumen…”
BackgroundPDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice
Rivers, L. E., Young, K. M., Rizzi, M., Jamen, F., Psachoulia, K., Wade, A., Kessaris, N., & Richardson, W. D. (2008) · Nature Neuroscience · doi:10.1038/nn.2220 · Cited by 961
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889 · cited 2×
“In addition, mice lacking the expression of specific oligodendrocyte markers like PLP and CNPase develop axonal degeneration independent of widespread demyelination, again suggesting that oligodendrocytes (and Schwann Cells in the periphery), independent of their function as generating the myelin sheath, are instrumen…”
BackgroundRetrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872 · cited 1×
“Adeno-viral (AAV) expression of IGF-1 or VEGF in mSOD1 mice has been shown to be beneficial in mSOD1 mice, delaying disease progression and increasing survival (Kaspar et al., 2003; Azzouz et al., 2004).”
BackgroundSelf-citationA Pericyte Origin of Spinal Cord Scar Tissue
Göritz, C., Dias, D. O., Tomilin, N., Barbacid, M., Shupliakov, O., & Frisén, J. (2011) · Science · doi:10.1126/science.1203165 · Cited by 858 · cited 1×
“Pericytes are also involved in glial scar formation upon a CNS insult (Goritz et al., 2011).”
BackgroundNon–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model
Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T., & Eggan, K. (2007) · Nature Neuroscience · doi:10.1038/nn1885 · Cited by 799 · cited 1×
“Just like microglia, mouse primary astrocytes derived from mSOD1 ALS mouse models are toxic to co-cultured embryonic stem cell derived or primary motor neurons (Di Giorgio et al., 2007; Nagai et al., 2007).”
BackgroundAstrocytes from familial and sporadic ALS patients are toxic to motor neurons
Haidet-Phillips, A. M., Hester, M. E., Miranda, C. J., Meyer, K., Braun, L., Frakes, A., Song, S., Likhite, S., Murtha, M. J., Foust, K. D., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1957 · Cited by 782 · cited 4×
“…from sALS astrocytes was dependent on the expression of the wild type SOD1 protein, supporting recent publications that oxidized wild type SOD1 as found in spinal cord of sALS patients could be a contributing factor in the pathogenesis of this non-mSOD1 mediated ALS(Haidet-Phillips et al., 2011).”
BackgroundResultInfluentialTurner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.012 · Cited by 737 · cited 12×
“…11C-PK11195, a ligand that highly binds to CNS microglia, as well as other CNS cells to a lesser extent, reveals apparent microgliosis in ALS patients, suggesting a correlation between the extent of microgliosis and damage to upper motor neurons, but not lower motor neurons (Turner et al., 2004).”
BackgroundInfluentialZawadzka, M., Rivers, L. E., Fancy, S. P. J., Zhao, C., Tripathi, R., Jamen, F., Young, K., Goncharevich, A., Pohl, H., Rizzi, M., et al. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.04.002 · Cited by 650
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Philips, T., & Robberecht, W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70015-1 · Cited by 646 · cited 1×
“Several studies have tried to explore whether the inhibition of the release of these proinflammatory factors is beneficial in the mSOD1 mouse model as well as in ALS patients (reviewed in (Philips and Robberecht, 2011)).”
BackgroundSelf-citationMicroglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis
Frakes, A. E., Ferraiuolo, L., Haidet-Phillips, A. M., Schmelzer, L., Braun, L., Miranda, C. J., Ladner, K. J., Bevan, A. K., Foust, K. D., Godbout, J. P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.013 · Cited by 638 · cited 2×
“A recent report suggested that microglial exert neurotoxicity through activation of NF-kB signaling, as microglial reduction of NF-kB signaling lead to significant prolongation of disease progression and life span of mSOD1 mice (Frakes et al., 2014).”
BackgroundOrigin of New Glial Cells in Intact and Injured Adult Spinal Cord
Barnabé-Heider, F., Göritz, C., Sabelström, H., Takebayashi, H., Pfrieger, F. W., Meletis, K., & Frisén, J. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.07.014 · Cited by 628 · cited 4×
“below) but it remains to be explored whether these cells contribute to astrogliosis in models of motor neuron loss (Carlen et al., 2009; Barnabe-Heider et al., 2010).”
BackgroundInfluentialKang, S. H., Li, Y., Fukaya, M., Lorenzini, I., Cleveland, D. W., Ostrow, L. W., Rothstein, J. D., & Bergles, D. E. (2013) · Nature Neuroscience · doi:10.1038/nn.3357 · Cited by 599 · cited 13×
“Loss of oligodendrocyte function both through an impairment of myelination and impairment in sustaining trophic support of surrounding motor neurons, underlies this neurotoxicity (Kang et al., 2013; Philips et al., 2013).”
BackgroundInfluentialSelf-citationPramatarova, A., Laganière, J., Roussel, J., Brisebois, K., & Rouleau, G. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03369.2001 · Cited by 482 · cited 1×
“When mSOD1 was selectively expressed in motor neurons alone it was insufficient to cause full blown motor neuron disease when compared to the ubiquitous expressing mSOD1 expressing animals (Pramatarova et al., 2001; Jaarsma et al., 2008).”
BackgroundModulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., Doykan, C. E., Wu, P. M., Gali, R. R., Iyer, L. K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62636 · Cited by 481
ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration
Zhong, Z., Deane, R., Ali, Z., Parisi, M., Shapovalov, Y., O'Banion, M. K., Stojanovic, K., Sagare, A., Boillee, S., Cleveland, D. W., et al. (2008) · Nature Neuroscience · doi:10.1038/nn2073 · Cited by 476 · cited 2×
“In mSOD1 mice, this disruption occurs well before the onset of motor neuron loss and is characterized by extravasation of erythrocytes and plasma proteins (Zhong et al., 2008).”
BackgroundLepore, A. C., Rauck, B., Dejea, C., Pardo, A. C., Rao, M. S., Rothstein, J. D., & Maragakis, N. J. (2008) · Nature Neuroscience · doi:10.1038/nn.2210 · Cited by 441
Self-citationNeuronal Exosomal miRNA-dependent Translational Regulation of Astroglial Glutamate Transporter GLT1
Morel, L., Regan, M., Higashimori, H., Ng, S. K., Esau, C., Vidensky, S., Rothstein, J., & Yang, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410944 · Cited by 430 · cited 1×
“Interestingly, exosomal release of miR124a from neurons is able to increase astrocyte GLT-1 expression levels in vitro as well as in vivo and could be an interesting target for therapeutic intervention (Morel et al., 2013).”
BackgroundSelf-citationBlood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis
Winkler, E. A., Sengillo, J. D., Sullivan, J. S., Henkel, J. S., Appel, S. H., & Zlokovic, B. V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1039-8 · Cited by 354 · cited 2×
“In ALS patients spinal cord, pericyte number is significantly affected, and plasma derived immunoglobulin G, fibrin and thrombin is accumulating in the parenchyma (Winkler et al., 2013).”
BackgroundSerio, A., Bilican, B., Barmada, S. J., Ando, D. M., Zhao, C., Siller, R., Burr, K., Haghi, G., Story, D., Nishimura, A. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300398110 · Cited by 345 · cited 2×
“Another study used human iPS derived astrocytes from a patient carrying a mTDP-43-M337V mutation and found that these cells were not neurotoxic to co-cultured iPS derived wild type or mTDP-43 M337V expressing motor neurons, although mutant astrocytes degenerated faster as compared to control derived astrocytes (Serio…”
BackgroundLymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral Sclerosis
Engelhardt, J. I., Tajti, J., & Appel, S. H. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540010026013 · Cited by 318 · cited 1×
“In ALS patient post mortem tissue, T-cell infiltrates were seen in both brain and spinal cord (Engelhardt et al., 1993).”
BackgroundYamanaka, K., Boillee, S., Roberts, E. A., Garcia, M. L., McAlonis-Downes, M., Mikse, O. R., Cleveland, D. W., & Goldstein, L. S. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802556105 · Cited by 309
Tripathi, R. B., Rivers, L. E., Young, K. M., Jamen, F., & Richardson, W. D. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3411-10.2010 · Cited by 277 · cited 1×
“In fact, even in neuro injury and disease conditions these progenitors remain committed to an oligodendroglial lineage in vivo (Kang et al., 2010; Tripathi et al., 2010; Zawadzka et al., 2010).”
BackgroundMolecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis
Corcia, P., Tauber, C., Vercoullie, J., Arlicot, N., Prunier, C., Praline, J., Nicolas, G., Venel, Y., Hommet, C., Baulieu, J.-L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052941 · Cited by 249 · cited 12×
“Another microglial imaging approach uses a radioligand of the translocator protein (TSPO), upregulated by microglia upon microglial activation (Corcia et al., 2012).”
BackgroundMethodInfluentialPresynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1
Yang, Y., Gozen, O., Watkins, A., Lorenzini, I., Lepore, A., Gao, Y., Vidensky, S., Brennan, J., Poulsen, D., Won Park, J., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.02.010 · Cited by 237 · cited 1×
“These astrocytic GLT-1 levels are regulated by KBBP in astrocytes which in turn is regulated by an unknown factor released by motor neurons (Yang et al., 2009).”
BackgroundSelf-citationPapadeas, S. T., Kraig, S. E., O'Banion, C., Lepore, A. C., & Maragakis, N. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103141108 · Cited by 213 · cited 1×
“On the other hand cervical transplantation of mSOD1 glial restricted precursor (GRP) and subsequent engraftment of progenitor cell derived mSOD1 expressing GFAP+ astrocytes in an otherwise wild type environment did induce motor neuron loss and forelimb paralysis (Papadeas et al., 2011).”
BackgroundZhong, Z., Ilieva, H., Hallagan, L., Bell, R., Singh, I., Paquette, N., Thiyagarajan, M., Deane, R., Fernandez, J. A., Lane, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38476 · Cited by 176 · cited 1×
“Lastly, selective depletion of mSOD1 from endothelial cells or skeletal muscle did not affect disease (Miller et al., 2006; Zhong et al., 2009).”
Background
Cited by
Brown, R. H., & Al-Chalabi, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1603471 · Cited by 2,125
Spreading of pathology in neurodegenerative diseases: a focus on human studies
Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Petrou, P., Gothelf, Y., Argov, Z., Gotkine, M., Levy, Y. S., Kassis, I., Vaknin-Dembinsky, A., Ben-Hur, T., Offen, D., Abramsky, O., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4321 · Cited by 303
Rodent Models of Amyotrophic Lateral Sclerosis
Philips, T., & Rothstein, J. D. (2015) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0567s69 · Cited by 294
Self-citation
Metadata
- Authors
- Philips, T., & Rothstein, J. D.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 262
- Pages
- 111-120
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2093791199
- Cited by
- 250
- References
- 37
- FWCI
- 14.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.